SCHEMBL855342

SCHEMBL855342

CC(C)(C)OC(=O)C(N)CCCCN

nearest known ligand 0.52

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
GSR P00390 1/20 0.52
CPB2 Q96IY4 5/20 0.44
GNAI3 P08754 1/20 0.41
GNAO1 P09471 1/20 0.41
GNAI1 P63096 1/20 0.41
DPP7 Q9UHL4 6/20 0.39
DPP8 Q6V1X1 3/20 0.39
DPP9 Q86TI2 3/20 0.39
DPP4 P27487 1/20 0.37
RNPEP Q9H4A4 1/20 0.37
NOS1 P29475 2/20 0.37
LTA4H P09960 1/20 0.37
NOS3 P29474 1/20 0.37
NOS2 P35228 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL866977 1.00 GSR (0.52) GSRCPB2GNAI3GNAO1GNAI1
SCHEMBL1310240 0.98 GSR (0.50) GSRCPB2GNAI3GNAO1GNAI1
Hydrochloric Acid SCHEMBL3088558 0.98 GSR (0.50) GSRCPB2GNAI3GNAO1GNAI1
SCHEMBL1323618 0.98 GSR (0.50) GSRCPB2GNAI3GNAO1GNAI1
Hydrochloric Acid SCHEMBL3088557 0.98 GSR (0.50) GSRCPB2GNAI3GNAO1GNAI1
SCHEMBL1309368 0.98 GSR (0.50) GSRCPB2GNAI3GNAO1GNAI1
SCHEMBL1309450 0.98 GSR (0.50) GSRCPB2GNAI3GNAO1GNAI1
SCHEMBL2131918 0.98 GSR (0.50) GSRCPB2GNAI3GNAO1GNAI1
SCHEMBL1308683 0.98 GSR (0.50) GSRCPB2GNAI3GNAO1GNAI1
SCHEMBL1308718 0.98 GSR (0.50) GSRCPB2GNAI3GNAO1GNAI1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 167 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119470406-A Phthalic dicarboxaldehyde disinfectant concentration detection test paper and preparation method thereof 山东新华莎罗雅生物技术有限公司 2025-02-18 CN claimed
EP-2167103-B1 SELF-ASSEMBLING AMPHIPHILIC POLYMERS AS ANTICANCER AGENTS ALLEXCEL INC (US) 2017-03-01 EP claimed
CN-101636169-B Self-assembling amphiphilic polymers as antiviral agents ALLEXCEL INC 2014-05-07 CN claimed
CN-101797210-A Use of lysine derivative for the conditioning of keratinic fibres, cosmetic composition containing it and process for the conditioning the fibres OREAL 2010-08-11 CN claimed
WO-2002053526-A1 NEW COMPOUNDS FOR USE AS INTERMEDIATES IN LINEAR BLOCK POLYMER AND NEW LINEAR BLOCK POLYMER ARTIMPLANT AB (SE) 2002-07-11 WO claimed
WO-2002053616-A1 NEW LINEAR BLOCK POLYMER ARTIMPLANT AB (SE) 2002-07-11 WO claimed
EP-1088020-A1 FUNCTIONALISED POLYMERS OF ALPHA-AMINO ACIDS AND THE METHOD OF PREPARATION THEREOF USTAV MAKROMOLEKULARNI CHEMIE AKADEMIE VED CESKE REPUBLIKY (CZ) 2001-04-04 EP claimed
WO-1999064495-A1 FUNCTIONALISED POLYMERS OF α-AMINO ACIDS AND THE METHOD OF PREPARATION THEREOF ÚSTAV MAKROMOLEKULÁRNÍ CHEMIE AKADEMIE VĚD ČESKÉ REPUBLIKY (CZ) 1999-12-16 WO claimed
US-5908960-A Compounds SMITHKLINE BEECHAM CORPORATION (US) 1999-06-01 US claimed
US-20250276966-A1 Nitrogen-Linked Benzisoxazole Sulfonamide Derivatives PFIZER (US) 2025-09-04 US disclosed
US-20250122183-A1 Nitrogen-Linked Benzisoxazole Sulfonamide Derivatives PFIZER (US) 2025-04-17 US disclosed
WO-2025074249-A1 NITROGEN-LINKED BENZISOXAZOLE SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF CANCER PFIZER INC. (US) 2025-04-10 WO disclosed
CN-119241502-B NSD3 degradation agent and preparation method and application thereof 四川大学华西医院 2025-02-28 CN disclosed
CN-119470406-A Phthalic dicarboxaldehyde disinfectant concentration detection test paper and preparation method thereof 山东新华莎罗雅生物技术有限公司 2025-02-18 CN disclosed
US-4658015-A ANTAGONIST OF VASSOPRESSIN AND OXYTOCIN SMITHKLINE BECKMAN CORPORATION (US) 1987-04-14 US disclosed
US-4604378-A CYCLIC POLYPEPTIDES SMITHKLINE BECKMAN CORPORATION (US) 1986-08-05 US disclosed
EP-0182627-A2 Basic V1-vasopressin antagonists SMITHKLINE BECKMAN CORPORATION (US) 1986-05-28 EP disclosed
EP-0174162-A2 Pharmaceutically active dipeptide derivatives THE WELLCOME FOUNDATION LIMITED (GB) 1986-03-12 EP disclosed
US-4543349-A Basic heptapeptide vasopressin antagonists SMITHKLINE BECKMAN CORPORATION (US) 1985-09-24 US disclosed
EP-0135379-A2 Basic hexa- and hepta-peptide vasopressin antagonists SMITHKLINE BECKMAN CORPORATION (US) 1985-03-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250122183-A1 Nitrogen-Linked Benzisoxazole Sulfonamide Derivatives CCNI, MKI67, CCNA1 GSR 933/4885CPB2 4542/4885GNAI3 1093/4885
US-20250276966-A1 Nitrogen-Linked Benzisoxazole Sulfonamide Derivatives CCNI, MKI67, CCNA1 GSR 966/4885CPB2 4507/4885GNAI3 1135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.